- Global Pharma News & Resources

Hormonal Contraceptives Market surpassed US$ 16.3 Bn in 2021 and is projected to accelerate at a CAGR of 4.3% from 2023 to 2032 | insightSLICE

The market for Hormonal Contraceptives was valued at US$ 16.3 billion in 2021 and is projected to increase at a CAGR of 4.3% from 2023 to 2032.

The market share, trends, analysis, and projections for the years 2022 to 2032 are just a few of the topics that will be covered in the report for the Global Hormonal Contraceptives Market. Herein, 2020 is used as the historical period, 2021 as the base year, and 2022 through 2032 as the actual prediction period in this study.

Access the sample report:

The competitive environment is taken into account in this study, which also offers top competitors in the global market for Hormonal Contraceptives manufacturing company overviews and forecasts.

In addition, the report will include information on important advancements, global and regional sales networks, business strategies, research and development initiatives, staff strength, and key executives for all significant market participants.

The key players of the Global Hormonal Contraceptives Market are:

The biggest companies present in the global hormonal contraceptives market which is covered in this report include Pfizer, Inc., Reckitt Benckiser Plc, Boehringer Ingelheim GmbH, BioSante Pharmaceuticals Inc., Ansell LTD., Bayer AG, Cipla Limited, Female Health Company, Johnson & Johnson, Mayer Laboratories, Merck & Co., Inc., Church & Dwight, Co., Inc., HLL Lifecare Limited, Mylan N.V., Teva Pharmaceutical Industries Limited, V-Care Pharma Pvt. Ltd., Warner Chilcott Company, Vardhman Life Care Pvt. Ltd., and Watson Pharmaceuticals, Inc.

Global trajectory of the hormonal contraceptives market:

Global demand for hormonal contraceptives is primarily being driven by rising awareness of such products, an increase in adolescent pregnancies, and government attempts to promote hormonal birth control.

The use of hormonal contraceptives has become a trusted and secure means of avoiding unplanned pregnancies. With the aid of ongoing hormone treatment or by way of one-time pills, a variety of tools and drugs are utilized to stop the ovulation and fertilization processes.

Due to urbanization and rising awareness among women of all ages, the use of hormonal contraceptives has significantly increased over the last few decades.

Over the previous two decades, the number of adolescent pregnancies has risen exponentially, which has had a considerable impact on the global usage of hormonal contraceptives.

The global market for hormonal contraceptives is expanding as a result of government measures to encourage their usage as a means of reducing population increase. Throughout the projected period, a steady expansion of the global market for hormonal contraceptives is anticipated.

Read more about the report inclusions:

Main parts of this report include:

The study includes an in-depth assessment of significant players with a majority share of the global market, with a concentration on all functioning business segments, and therefore would identify the industry’s segment focused on hormonal contraceptives.

It will also estimate the market shares of well-known firms in the global market for hormonal contraceptives. As an illustration, GlaxoSmithKline plc runs its business through three divisions: pharmaceuticals, vaccines, and consumer health. GlaxoSmithKline plc reported revenues of USD 41,974.1 million in 2019.

In accordance with the company’s assessment of its product segments, the pharmaceuticals business segment accounted for the majority of the company’s revenues in 2019, with North America serving as its largest earnings geographic location.

With a total revenue of around US$ 21860.0 million in 2019, the firm’s pharmaceuticals division provides hormonal contraceptive products and solutions.

The research takes into consideration crucial competitive data, including the strategic plan, brand portfolio, important developments, SWOT analysis, and the emphasis on the development and research of each of the hormonal contraception producers.

The participants in the market’s trade and supply chains, as well as their contributions, will be taken into account in the analysis of the worldwide hormonal contraceptive market. All of the items in the company’s hormonal contraceptives business sector would be the main focus of the product portfolio.

Similar to this, the recent developments section would concentrate on the most recent corporate activities, such as major alliances, mergers and acquisitions, newly introduced products, and expansion in the worldwide hormonal contraceptives market.

Related reports:

Global Urinary Catheter Market:

Global Coronary Guidewires Market:

Global Hormonal Contraceptives Market Key Segments:

By Hormone

  • Combination Hormonal Contraceptives
  • Progestin Only

By Method

  • Pill
  • Intrauterine Device (IUD)
  • Injectable
  • Vaginal Ring
  • Implant
  • Patch

By Sales Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Gynecology clinics
  • Others

By Geography:

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • India
    • China
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Rest of South America

Regional performance of Hormonal Contraceptives Market

In the year 2019, North America accounted for the biggest share of the global market for hormonal contraceptives. This region is also expected to continue to hold a dominant position during the forecast period.

In the United States and Canada, there is a very high level of sexual health awareness, which has influenced the early acceptance of hormonal contraceptives.

The market for hormonal contraceptives in North America is expanding as a result of factors including rising unwanted pregnancies in the area, ease of access, and the presence of top producers of hormonal contraceptives.

Government actions to support birth control measures are causing a rise in the knowledge of the usage of hormonal contraceptives in Asia Pacific, which is boosting the market for hormonal contraceptives.

Due to rising acceptance and a developing pharmaceutical manufacturing business in the area, Asia Pacific is predicted to have the quickest growth over the projected period.

Proceed to purchase:

insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at

Contact us:

Alex R

+1 707 736 6633

Linkedin | Twitter

Editor Details

Last Updated: 01-Dec-2022